highly significantp = 0.001
Moreover, MTA1-knockdown tumors treated with compounds had further response, and the differences versus EV-Ctrl became highly significant (p = 0.001 for resveratrol, p = 0.0004 for PTER).
Moreover, MTA1-knockdown tumors treated with compounds had further response, and the differences versus EV-Ctrl became highly significant (p = 0.001 for resveratrol, p = 0.0004 for PTER).
Xenografts expressing MTA1shRNA exhibited markedly reduced tumor growth at week 5 post-transplantation with marginal significance versus EV-Ctrl (p = 0.05).